Scinai Immunotherapeutics Ltd. SEC filings SCNI
Scinai Immunotherapeutics Ltd. has 495 filings in SEC EDGAR's recent list, going back to Nov 13, 2014. Its latest annual report, Form 20-F, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on May 15, 2023, covering the quarter ended Mar 31, 2023. The most recent current report (Form 6-K) was filed on Oct 20, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
Showing 1 filing. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- SCNI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Jerusalem, Israel
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1611747
- Former names
- BiondVax Pharmaceuticals Ltd. (until Aug 28, 2023)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.